Clinical Trial Update: Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 results report on the safety and immunogenicity of intranasal BPZE1 vaccination in healthy adults for pertussis. The trial has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• BPZE1 (Bordetella pertussis live attenuated vaccine BPZE1)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pertussis, Pertussis Immunisation | Phase 2 | Status: COMPLETED | Results posted: 2022-02-03